BioLineRx (BLRX) Inventory Average (2023 - 2025)

BioLineRx's Inventory Average history runs 3 years deep, the most recent figure standing at $2.2 million for Q4 2025.

• On a quarterly basis, Inventory Average fell 35.28% year-over-year to $2.2 million in Q4 2025; TTM through Dec 2025 was $2.2 million, a 35.28% decrease from a year earlier, with the FY2025 full-year figure at $2.6 million, up 3.83% from the prior year.
• Inventory Average slipped to $2.2 million in Q4 2025 per BLRX's latest filing, from $2.5 million in the prior quarter.
• Across five years, Inventory Average topped out at $3.6 million in Q3 2024 and bottomed at $1.7 million in Q4 2023.
• The 3-year median for Inventory Average is $3.1 million (2025), against an average of $2.8 million.
• Across the five-year window, Inventory Average jumped 102.39% in 2024 and plunged 35.28% in 2025, its largest moves.
• Year by year, Inventory Average stood at $1.7 million in 2023, then soared by 102.39% to $3.3 million in 2024, then slumped by 35.28% to $2.2 million in 2025.
• Per Business Quant, the three latest BLRX Inventory Average figures stand at $2.2 million (Q4 2025), $2.5 million (Q3 2025), and $3.1 million (Q2 2025).